Logo BizupsLogo Bizups
    • Investors
    • Accelerators
    • Incubators
    • Startups

      Posts

      • Home
      • Posts
      Lumira Ventures
      Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government
      • . Oct. 11, 2024, 9:49 p.m.

      Edesa Biotech to Receive Up To C$23 Million …

      Lumira Ventures
      Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors
      • . Oct. 11, 2024, 9:49 p.m.

      Specific Biologics Announces Additional Investment and Appointment of …

      Lumira Ventures
      Lumira Ventures Portfolio Company enGene (Nasdaq: ENGN) Debuts as Publicly Traded Genetic Medicines Company
      • . Oct. 11, 2024, 9:49 p.m.

      Lumira Ventures Portfolio Company enGene (Nasdaq: ENGN) Debuts …

      Lumira Ventures
      Summer 2024 Analyst Position Open
      • . Oct. 11, 2024, 9:49 p.m.

      Summer 2024 Analyst Position Open

      Lumira Ventures
      AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care
      • . Oct. 11, 2024, 9:49 p.m.

      AmacaThera Closes Series A Extension to Advance Clinical …

      Lumira Ventures
      World’s First Patients Treated With Novel Edison® Histotripsy System
      • . Oct. 11, 2024, 9:49 p.m.

      World’s First Patients Treated With Novel Edison® Histotripsy …

      Lumira Ventures
      Cyrano Therapeutics Secures $9.0 Million Series B Financing to Advance Clinical Development of CYR-064 for Treatment of Post-Viral Smell Loss
      • . Oct. 11, 2024, 9:49 p.m.

      Cyrano Therapeutics Secures $9.0 Million Series B Financing …

      Lumira Ventures
      COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures
      • . Oct. 11, 2024, 9:49 p.m.

      COUR Pharmaceuticals Secures $105 Million in Series A …

      Lumira Ventures
      Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
      • . Oct. 11, 2024, 9:49 p.m.

      Endogenex Receives IDE Approval to Initiate Pivotal Clinical …

      Lumira Ventures
      Transposon Announces Final Results from a Phase 2 Study of its LINE-1 Reverse Transcriptase Inhibitor TPN-101 for the Treatment of Progressive Supranuclear Palsy and Interim Results from a Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
      • . Oct. 11, 2024, 9:49 p.m.

      Transposon Announces Final Results from a Phase 2 …

        • 86
        • 87
        • 88
        • 89
        • 90
        • 91
        • 92
        • 93
        • 94

      Search Posts

      Ctegories

        Last Posts

          Media

            Logo Bizups

            Uncover the Startup Ecosystem

            • Info@bizups.info

            Links

            • Investors
            • Accelerators
            • Incubators
            • Startups

            Links

            • Programs
            • Events
            • Mentors
            • Posts
            • Live

            Support

            • About Us
            • User Guide
            • Disclaimer
            • Privacy Policy
            • Contact Us

            Social Media

            © Bizups.info. All rights reserved.
            Login
            Sign In/Sign Up with linkedin
            Signup

            Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.

            We found a number of people with your first name. When you find your first name in this list, select it

            This section is for the registration of real people's first name, it will be canceled in case of registration with name/organization or startup profile. After registering First name, you can add and manage your startup.Entering all requested information is mandatory